President Amy Gutmann and EVP Craig Carnaroli announced the promotion of Gregory (Greg) J. Pellicano to Vice President for Audit, Compliance and Privacy which was effective June 22 from his prior role as the Associate Vice President. Mr. Pellicano, along with his 33-member professional staff, provide assurance and advisory services and oversee the compliance and privacy programs for both the University and Penn Medicine.
Since joining Penn in October 2015, Mr. Pellicano has overseen and provided strategic direction to this important function. During his tenure, he reshaped the audit work plan to focus on higher level, strategic risks. More specifically, he has worked collaboratively across the University to address risks in the areas of information security, research compliance and clinical trials management. In addition, Mr. Pellicano has called attention to the risks related to third-party outsourcing arrangements.
Mr. Pellicano has refined the risk-based internal audit planning methodology, yielding a 20% efficiency by creating enhanced capacity. In the area of privacy, he has furthered Penn’s strong reputation by enhancing both the monitoring and investigatory functions at multiple sites at the Health System. In addition, he has worked to integrate the comparable functions of Penn’s recently acquired hospitals with his Office. Finally, he restructured the institutional compliance function to enhance its effectiveness.
Prior to joining Penn, he served as Vice President and Deputy Chief Compliance Officer at Shire Pharmaceuticals. He has also held various senior level risk and assurance positions at several Fortune 500 companies during his 33-year professional career. His appointment was approved by the Trustees in June.